Home Page
07:33:07 EDT Tue 02 Sep 2014
Enter Symbol
or Name
USA
CA



AMPIO PHARMACEUTICALS INC
Symbol U : AMPE
Recent Sedar Documents

Ampio Pharmaceuticals Announces Participation at Upcoming Investor Conference

2013-01-22 04:00 ET - News Release

GREENWOOD VILLAGE, Colo., Jan. 22, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE) announced today that Mike Macaluso, Chairman and CEO, and Dr. David Bar-Or, Director and CSO, will present at "NINE"; Noble Financial Capital Markets' Ninth Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida, on Tuesday, January 22 at 12pm Eastern Time.

(LOGO: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

At the time of the presentation, a live audio and high-definition video webcast of Ampio Pharmaceuticals, Inc. presentation and a copy of the presentation materials will be available on the Company's web site www.ampiopharma.com, or through the Noble Financial websites: www.noblefcm.com or http://www.nobleresearch.com/NINE/home.htm. Ampio Pharmaceuticals, Inc. recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will also be archived on www.ampiopharma.com for 90 days following the event.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on the rapid development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.  It aims to provide medicines to improve the health and quality of life of patients with minimal side effects. Ampio is developing compounds that decrease inflammation by 1) inhibition of specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level or 2) activation of a specific phosphatase or depletion of the available phosphate needed for the inflammation process. For more information visit: www.ampiopharma.com.

About Noble Financial

Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on life sciences, technology and media, emerging growth, companies. The company has offices in New York, Boston, New Jersey, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120-150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com

Forward Looking Statement

Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, successful commercialization and marketing of Zertane™ and the combination drug in Korea, and changes in business conditions and similar events. The risks and uncertainties involved include those detailed from time to time in Ampio's filings with the Securities and Exchange Commission, including Ampio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q

Investor Contact:
Rick Giles
Director of Investor Relations
Ampio Pharmaceuticals, Inc.
Direct (720) 437-6530
Email: rgiles@ampiopharma.com

SOURCE Ampio Pharmaceuticals, Inc.

© 2014 Canjex Publishing Ltd. All rights reserved.